Published in Antimicrob Agents Chemother on January 01, 1979
The chemistry and pharmacology of privileged pyrroloquinazolines. Medchemcomm (2015) 0.75
Chemotherapy of systemic mycoses (first of two parts). N Engl J Med (1974) 4.20
Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism). Proc Natl Acad Sci U S A (1972) 4.09
Flucytosine. Ann Intern Med (1977) 2.14
In vitro studies with combinations of 5-fluorocytosine and amphotericin B. Antimicrob Agents Chemother (1975) 2.10
Chemotherapy of systemic mycoses (second of two parts). N Engl J Med (1974) 1.73
Synthetic medium for susceptibility testing. Antimicrob Agents Chemother (Bethesda) (1970) 1.31
Synergistic action of amphotericin B and rifampin on Candida albicans. Am Rev Respir Dis (1974) 1.26
Inhibition of potentially pathogenic yeastlike fungi by clotrimazole in combination with 5-fluorocytosine or amphotericin B. Antimicrob Agents Chemother (1976) 1.20
Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B. J Infect Dis (1977) 1.18
Schedule-dependent antitumor effects of methotrexate and 5-fluorouracil. Cancer Res (1977) 1.16
In-vitro effects of Candida albicans of amphotericin B combined with other antibiotics. Preliminary observations. Scand J Infect Dis Suppl (1976) 1.01
Antifungal agents used for deep-seated mycotic infections. Mayo Clin Proc (1977) 0.83
Activity of selected 2,4-diaminoquinazolines against Candida albicans in vitro. Proc Soc Exp Biol Med (1976) 0.81
In vitro and in vivo activity of 2,4-diamino-6-(2-(3,4-dichlorophenyl)acetamido) quinazoline against Cryptococcus neoformans. Proc Soc Exp Biol Med (1976) 0.79
Role of infection in chronic bronchitis. Am Rev Respir Dis (1976) 1.81
Activity of cefoperazone and two beta-lactamase inhibitors, sulbactam and clavulanic acid, against Bacteroides spp. correlated with beta-lactamase production. Antimicrob Agents Chemother (1982) 1.73
The kinetics of early inflammatory events during experimental pneumonia due to Legionella pneumophila in guinea pigs. J Infect Dis (1983) 1.67
Legionnaires' disease in patients with associated serious disease. Ann Intern Med (1979) 1.50
Interaction of warfarin and nonsystemic gastrointestinal drugs. Clin Pharmacol Ther (1971) 1.44
Vancomycin therapy of bacterial meningitis. Am J Dis Child (1973) 1.43
A revised scheme for the evaluation of automatic instruments for use in clinical chemistry. Ann Clin Biochem (1974) 1.40
Endometritis related to Chlamydia trachomatis infection. Ann Intern Med (1981) 1.35
The relationship of infection and DNA-synthesizing cells in human blood. J Lab Clin Med (1967) 1.30
Legionnaires' pneumonia after aerosol exposure in guinea pigs and rats. Am Rev Respir Dis (1982) 1.23
Vancomycin for treatment of bacterial meningitis. Rev Infect Dis (1982) 1.22
Antibacterial activity of gentamicin sulfate in tissue culture. Appl Microbiol (1970) 1.22
Legionnaires' pneumonia after intratracheal inoculation of guinea pigs and rats. Lab Invest (1982) 1.21
Evidence of prior pelvic inflammatory disease and its relationship to Chlamydia trachomatis antibody and intrauterine contraceptive device use in infertile women. Am J Obstet Gynecol (1983) 1.21
Endocarditis caused by a new species of Pasteurella. Ann Intern Med (1972) 1.16
Purified influenza vaccine: clinical and serologic responses to varying doses and different routes of immunization. J Infect Dis (1970) 1.13
Plasmodium falciparum in Kenya: high prevalence of drug-resistance-associated polymorphisms in hospital admissions with severe malaria in an epidemic area. Ann Trop Med Parasitol (2001) 1.10
Dihydrofolate reductase from Trypanosoma equiperdum. I. Isolation, partial purification, and properties. Mol Pharmacol (1967) 1.09
A recommended scheme for the evaluation of kits in the clinical laboratory. Ann Clin Biochem (1980) 1.09
Farmer's lung disease in Vermont. Respiration (1979) 1.07
Cytomegalovirus encephalitis in immunologically normal adults. Successful treatment with vidarabine. JAMA (1977) 1.04
Carbocyclic analogues of the potent cytidine deaminase inhibitor 1-(beta-D-ribofuranosyl)-1,2-dihydropyrimidin-2-one (zebularine). J Med Chem (1998) 1.03
Vidarabine therapy for severe herpesvirus infections. An unusual syndrome of chronic varicella and transient immunologic deficiency. JAMA (1976) 1.03
Respiratory symptoms and lung function in a sample of Vermont dairymen and industrial workers. Am J Public Health (1980) 1.03
Side effects of minocycline: a double-blind study. Antimicrob Agents Chemother (1977) 1.03
Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1. Biochem Pharmacol (1993) 1.01
Serum and secretory antibodies in patients with chronic bronchitis. Arch Intern Med (1973) 0.99
The penetration of cephalothin into synovial and other body fluids. Curr Ther Res Clin Exp (1968) 0.99
Lack of association between genital mycoplasmas and infertility. N Engl J Med (1984) 0.98
Comparative properties of schistosomal and filarial dihydrofolate reductases. Biochem Pharmacol (1972) 0.98
Hemophilus influenzae septic arthritis. A mimicker of gonococcal arthritis. Arthritis Rheum (1974) 0.98
Legionnaires' disease following renal transplantation. Transplant Proc (1979) 0.97
Synthesis of 1,3-diazepin-2-one nucleosides as transition-state inhibitors of cytidine deaminase. J Med Chem (1980) 0.95
The protective effect of intraperitoneal splenic autotransplants in mice exposed to an aerosolized suspension of type III Streptococcus pneumoniae. Blood (1979) 0.94
2,4-Diaminothieno[2,3-d]pyrimidine analogues of trimetrexate and piritrexim as potential inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase. J Med Chem (1993) 0.94
Tobramycin therapy of pulmonary infections in patients with cystic fibrosis. Curr Ther Res Clin Exp (1974) 0.93
Chloramphenicol. A 1981 view. Arch Intern Med (1981) 0.92
Distressing side-effects of minocycline hydrochloride. Arch Intern Med (1976) 0.92
Synthesis of pyrimidin-2-one nucleosides as acid-stable inhibitors of cytidine deaminase. J Med Chem (1986) 0.92
Deposition of bismuth by Yersinia enterocolitica. Med Microbiol Immunol (1992) 0.92
Amplification of antibody production by phosphorothioate oligodeoxynucleotides. J Lab Clin Med (1996) 0.90
Cyclic urea nucleosides. Cytidine deaminase activity as a function of aglycon ring size. J Med Chem (1981) 0.90
Bactericidal antibodies to Hemophilus influenzae. Proc Soc Exp Biol Med (1971) 0.88
Presence and properties of dihydrofolate reductases within the genus Crithidia. Biochim Biophys Acta (1969) 0.88
Effects of folate deficiency on the metastatic potential of murine melanoma cells. Cancer Res (1988) 0.88
Side effects of minocycline: different dosage regimens. Antimicrob Agents Chemother (1977) 0.87
Increased susceptibility of Neisseria gonorrhoea from a rural area. Antimicrob Agents Chemother (1973) 0.87
Inhibition of in vitro and in vivo HIV replication by a distamycin analogue that interferes with chemokine receptor function: a candidate for chemotherapeutic and microbicidal application. J Med Chem (1998) 0.86
Hemophilus parainfluenzae peritonitis associated with an intrauterine contraceptive device. Am J Obstet Gynecol (1977) 0.86
Furanose-pyranose isomerization of reduced pyrimidine and cyclic urea ribosides. J Med Chem (1986) 0.86
Severe Mycoplasma pneumoniae pneumonia. Respiration (1976) 0.84
Comparative activity and properties of lactate dehydrogenase, xanthine dehydrogenase, and dihydrofolate reductase in normal and Brugia pagangi-infected Aedes aegypti. J Parasitol (1977) 0.83
Antibiotic therapy in obstetrics and gynecology. Clin Obstet Gynecol (1976) 0.83
Antibodies to Chlamydia trachomatis in cervical secretions and serum: effect of blood in such secretions. Fertil Steril (1985) 0.83
Correlated studies of interstitial pulmonary disease. Chest (1976) 0.83
Technical bulletin No. 35. Investigation of the validity of temperature correction factors for serum aspartate and alanine transaminases. Ann Clin Biochem (1975) 0.82
Dihydrofolate reductase from Trypanosoma equiperdum. II. Inhibition by 2,4-diaminopyrimidines and related heterocycles. J Med Chem (1969) 0.82
Xanthine oxidase-mediated oxidation of epinephrine. Biochem Pharmacol (1971) 0.82
Dihydrofolate reductases within the genus Trypanosoma. Exp Parasitol (1969) 0.82
Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs. Cancer Res (1985) 0.81
B-cell proliferation and differentiation in common variable immunodeficiency patients produced by an antisense oligomer to the rev gene of HIV-1. Clin Immunol Immunopathol (1996) 0.81
Inhibition of dihydrofolate reductases by derivatives of 2,4-diaminopyrroloquinazoline. Biochem Pharmacol (1979) 0.81
The gel-filtration behaviour of dihydrofolate reductases from culture forms of trypanosomatids. Biochim Biophys Acta (1969) 0.81
Lack of protection by pneumococcal vaccine after splenectomy in mice challenged with aerosolized pneumococci. J Trauma (1983) 0.80
Studies of human leukocyte culture as an in vitro test of delayed hypersensitivity. Am Rev Respir Dis (1967) 0.80
Effect of osmotic diuresis on gentamicin-induced nephrotoxicity in rats. Arch Toxicol (1980) 0.80
Elevated SGOT levels after carbenicillin. N Engl J Med (1970) 0.79
Oxidation of pteridine derivatives in mice. Biochem Pharmacol (1977) 0.79
Acquired chorioretinitis due to toxoplasmosis. Ann Intern Med (1979) 0.79
A phase I study of trimetrexate, an analog of methotrexate, administered monthly in the form of nine consecutive daily bolus injections. Cancer Chemother Pharmacol (1987) 0.78
Phase I clinical and pharmacokinetic study of trimetrexate using a daily x5 schedule. Cancer Res (1988) 0.78
Clinical pharmacology and metabolism of trimetrexate. Semin Oncol (1988) 0.77
Activity of trimethoprim (TMP), sulphamethoxazole (SMX) and the combination against Bacteroides fragilis group isolates. J Antimicrob Chemother (1983) 0.77
Synthesis and antineoplastic evaluations of 5,8-bis[(aminoalkyl)amino]-1-azaanthracene-9,10-diones. J Med Chem (1985) 0.77
Trypanocidal properties of 5'-O-Sulfamoyladenosine, a close structural analog of nucleocidin. Exp Parasitol (1970) 0.77
Cellular pharmacology of chloroquinoxaline sulfonamide and a related compound in murine B16 melanoma cells. Biochem Pharmacol (1988) 0.77
Phosphofructokinase activity in particulate-free extracts of Trypanosoma (Trypanozoon) rhodesiense. Comp Biochem Physiol B (1971) 0.76
Dihydrofolate reductase inhibitors as potential drugs. Med Res Rev (1981) 0.76
Inhibition of mammalian dihydrofolate reductase by selected 2,4-diaminiquinazolines and related compounds. J Med Chem (1974) 0.76
Synthesis and antitumor activities of unsymmetrically substituted 1,4-bis[(aminoalkyl)amino]anthracene-9,10-diones and related systems. J Med Chem (1986) 0.76
Presence and properties of dihydrofolate reductases within the genus Trypanosoma. Br J Pharmacol (1968) 0.75
Legionnaires' pneumonia in guinea pigs and rats produced by aerosol exposure. Chest (1983) 0.75
Susceptibility of Neisseria meningitidis to josamycin. Curr Ther Res Clin Exp (1976) 0.75
Use of newer amino group reagents for the detection and determination of kanamycin. Anal Chem (1973) 0.75
Contraception and cervical colonization with mycoplasmas and infection with cytomegalovirus. Fertil Steril (1975) 0.75
Letter: Treatment of sinusitis. N Engl J Med (1974) 0.75
Historical case report of Sir William Johnson, the Mohawk Baronet. Am J Gastroenterol (1992) 0.75
Artifacts resembling Chlamydia trachomatis. N Engl J Med (1980) 0.75
Bugs along the lifeline. Emerg Med (N Y) (1978) 0.75
Genital mycoplasmas and inhibitory substances in amniotic fluid: a negative result. Am J Obstet Gynecol (1979) 0.75
Endocarditis: an overview. Heart Lung (1982) 0.75
Intraerythrocytically administered tubercidin (7-deazaadenosine) and immune protection of mice. Proc Soc Exp Biol Med (1974) 0.75
Chloramphenicol: an impatient study of use and abuse. J Infect Dis (1978) 0.75
Protein and antibody in lavage fluid of guinea pigs with Legionella pneumophila pneumonia. Zentralbl Bakteriol Mikrobiol Hyg A (1983) 0.75
Legionnaires' disease and fever of unknown origin. Scand J Infect Dis (1982) 0.75
Gentamicin dosage and lean body mass. Ann Intern Med (1977) 0.75
Comparative effects of diverse mammalian sera on the uptake and protein incorporation of 14C-labelled amino acids by blood stream forms of T. brucei and T. rhodesiense in vitro. Trans R Soc Trop Med Hyg (1969) 0.75
Intrauterine contraceptive device and increased serum immunoglobulin levels. Obstet Gynecol (1973) 0.75